Product Information
ENBRACE HR SOFTGEL is a brand product labeled by Jaymac Pharma, priced at $4.4791 per EA under NDC 64661065030. Its NADAC has been published 304 times since Dec 18, 2019.
Strength
6.4; 800; 500; 50; 25; 13.6; 25; 1; 2.5; 5.23; 24; 1; 25; 12; 25; 1 mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1
Manufacturer
Jaymac PharmaNDC
64661065030
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Approval Type
Unapproved
On Market Since
8/12/2011
Pharmacological Classes
Price Statistics
The NADAC for ENBRACE HR SOFTGEL has been published 304 times since Dec 18, 2019, and over the history we have for it it has risen 2.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4791 per EA |
|---|---|
| All-time high | $4.7828 (Aug 14, 2024) |
| All-time low | $4.2158 (Jul 21, 2021) |
| 52-week high | $4.4979 |
| 52-week low | $4.4782 |
| Median price | $4.6374 |
| Average price | $4.5916 |
| Largest weekly change | +10.0% (Aug 4, 2021) |
| Weeks tracked | 304 |
| Tracking since | Dec 18, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, and PHOSPHATIDYL SERINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Jaymac Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, and PHOSPHATIDYL SERINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Folate Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENBRACE HR SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for ENBRACE HR SOFTGEL, manufactured by Jaymac Pharma, is $4.4791 per EA (NDC 64661065030), effective Sep 30, 2026.
How has the price of ENBRACE HR SOFTGEL changed over time?
Over the history we have for it, the NADAC for ENBRACE HR SOFTGEL has risen 2.8%. It has been tracked across 304 weekly CMS publications since Dec 18, 2019.
What are the highest and lowest recorded NADAC prices for ENBRACE HR SOFTGEL?
Since Dec 18, 2019, the NADAC for ENBRACE HR SOFTGEL has ranged from a low of $4.2158 (Jul 21, 2021) to a high of $4.7828 (Aug 14, 2024), with a median of $4.6374 per EA.
Are there cheaper alternatives to ENBRACE HR SOFTGEL?
No other NADAC-published product currently shares the active ingredient and strength of ENBRACE HR SOFTGEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENBRACE HR SOFTGEL?
ENBRACE HR SOFTGEL (NDC 64661065030) is labeled by Jaymac Pharma, and CMS classifies it as a brand product.